Syngene shares dip despite completing first US biologics site acquisition
Despite announcing the completion of its first biologics site acquisition in the US, Syngene, the contract research arm of ...
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing ...
The Independent Singapore News1d
Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs
Johor is set to become Asia's largest insulin hub as India's leading biotechnology firm, Biocon Ltd, invests another RM1.1 ...
Center for Biosimilars1d
Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD
Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...